RYTM
Rhythm Pharmaceuticals
$89.47
+$0.20 (+0.22%)Oct 26, 2026
Key metrics
The numbers that frame RYTM today
- Market cap
- $6.16B
- Gross margin
- 89%
- EV / Sales
- 25.4
- ROIC
- -62.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $74.51
- 52wk High
- $122.20
Growth
Revenue and earnings trend for RYTM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RYTM
Is Rhythm Pharmaceuticals a good buy?
Hold. Rhythm Pharmaceuticals has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Rhythm Pharmaceuticals is selling at a high price.
What is the market capitalization of RYTM?
Rhythm Pharmaceuticals's market capitalization is $6.16B.
What is the 52-week high for RYTM stock?
The 52-week high for Rhythm Pharmaceuticals is $122.20. The current close of $89.47 is 26.8% below that high.
What is the 52-week low for RYTM stock?
The 52-week low for Rhythm Pharmaceuticals is $74.51. The current close of $89.47 is 20.1% above that low.
Does RYTM stock pay dividends?
Rhythm Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RYTM?
Rhythm Pharmaceuticals's Debt / Equity ratio is 0.04.